What does progression-free survival mean for breast cancer patients?

Education, collaboration and communication in global cancer control

Treatment updates in Merkel cell carcinoma

Zoptarelin no better than doxarubicin for second-line advanced endometrial cancer

Immunotherapy trials and hyperprogressive disease

First-in-human phase 1 study of TAK-931 for solid tumours

Web-mediated follow-up via patient-reported outcomes vs. routine surveillance in lung cancer patients

The CAPTIVATE trial of ibrutinib and venetoclax as a first line treatment for CLL patients

Linking Lynch Syndrome and microsatellite instability in tumours

Editor’s Choice for May 2018

Movement and growth of cells throughout the leptomeningeal space

Diagnostics and classification of brain tumours